To access all features and enjoy the full functionality of this site, please ensure your browser is up-to-date. For IE8 users, the most recent version is IE11.

    TECNISTM Toric IOL

    TECNISTM Toric IOL

    To order this product, please contact your sales rep. 
    May not be available for all countries.

     

     

    tecnismonofocal_logo.png

    Instructional Guides

    Instructional Guides

    Instructional Guides

    Excellent Outcomes for Patients with Astigmatism

    Empower your patients’ vision with proven optical quality. The TECNISTM Toric IOL delivers sharp vision, good low-light performance and long-term sustainability for patients with astigmatism.1,2

    Optimize your outcomes with the TECNIS Toric Calculator.

    High-quality performance is just as critical for patients with astigmatism. The TECNISTM Toric IOL not only delivers excellent spherical correction but beautifully sharp vision as well.1

    Excellent astigmatism correction meets superior image contrast:

    • 94% of eyes achieved ≤ 0.50 diopters of residual refractive cylinder*2
    • 88% of patients achieved monocular corrected distance visual acuity of 20/20 or better3
    • Higher image contrast with TECNISTM Toric IOLs4

    MTF at 50 c/mm White, 5 mm Pupil4

    Up to 31% improved image contrast.

    MTF at 50 c/mm White, 3 mm Pupil4

    Up to 16% improved image contrast.

    Modular Transfer Function (MTF) is a measure of the amount of contrast transferred by the optics in a visual system. The higher the MTF value, the more contrast transferred to the image, resulting in higher image contrast. AcrySof is a trademark of Novartis AG Corp.

    TECNISTM Toric IOLs are designed for real-world conditions, empowering you to deliver high-confidence driving at night without distance glasses**3 — as well as good low-light performance for patients with astigmatism.

    Difficulty With Driving at Night Without Glasses at 6 Months†3

    91.9% of patients (ZCT150) reported no difficulty with night driving — without glasses.

    Trust your outcomes to an IOL that delivers exceptional postoperative rotational stability, stunning visual performance and high patient satisfaction.

    2.74° mean axis change between baseline and 6 months.3

    Unlike another leading IOL, TECNISTM IOL material is not associated
    with glistenings,5-9 which can inhibit your patients’ vision. Glistenings
    cause light scatter, which can result in a reduction in image contrast.6-10

    97% of patients would elect to have the TECNISTM Toric IOL again.3

    OPTIC CHARACTERISTICS1

    Powers:

    +5.0 D to +34.0 D in 0.5 diopter increments.                                                                 
    Model Numbers:
    ZCT100
    		 ZCT150 ZCT225 ZCT300 ZCT375 ZCT450 ZCT525 ZCT600 ZCT700 ZCT800
    Cylinder Powers – IOL Plane: 1.00 D 1.50 D 2.25 D 3.00 D 3.75 D 4.50 D 5.25 D 6.00 D 7.00 D 8.00 D
    Cylinder Powers – Corneal Plane: 0.69 D 1.03 D 1.54 D 2.06 D 2.57 D 3.08 D 3.60 D 4.11 D 4.80 D 5.48 D

    Diameter:

    6.0 mm

    Shape:

    Biconvex, anterior toric aspheric surface, square optic edge

    Material:

    UV-absorbing hydrophobic acrylic

    Refractive Index:

    1.47 at 35° C

    Edge Design:

    ProTEC frosted, continuous 360° posterior square edge

    BIOMETRY

    CONTACT ULTRASOUND

    OPTICAL

    A-Constant:

    118.8‡

    119.3§

    Theoretical AC Depth:

    5.4 mm

    5.7 mm

    Surgeon Factor:11

    1.68 mm

    1.96 mm

    HAPTIC CHARACTERISTICS1

    Overall Diameter:

    13.0 mm

    Configuration:

    Tri-Fix design, modified C, integral with optic

    Material:

    UV-absorbing hydrophobic acrylic

    Design:

    Haptics offset from optic

     

    View full product specifications (PDF)

     

    IOL INSERTION

    Recommended insertion instruments:

    FOOTNOTES

    *In a separate (IDE) study, 72.3% of ZCT150 eyes achieved ≤ 0.50 diopters of residual refractive cylinder. By comparison, 69.3% AcrySof® IQ Toric SA60T3 eyes achieved ≤ 0.50 D of residual refractive cylinder.
    **As control eyes had ≤1.5 D of preoperative Kcyl, results for all toric eyes pooled are not to be compared to control values.
    †Difficulty with certain activities without glasses at 6 months, bilateral subjects in the randomized control arm and open label arm safety population.
    ‡ Derived from clinical evaluation results of the TECNISTM 1-Piece IOL Platform for optical biometry.
    § A-Constant theoretically derived for ultrasound biometry.

     

    REFERENCES


    1. TECNISTM Toric 1-Piece IOL DfU OUS - Z311207, Rev. C, 11/2019. REF2020CT4322.
    2. Black D. Efficacy of hydrophobic acrylic toric IOL to correct astigmatism in cataract patients. Presented at ASCRS  San Diego, Calif. May, 2015. 
    3. Summary of Safety and Effectiveness Data (SSED) TECNISTM Toric 1-Piece IOL - PMAP980040/S039 - April 15, 2013. REF2021CT4224.
    4. DOF2015OTH0006 - Franssen L. TECNISTM and competitor toric IOL MTF data. 4 May 2015.
    5.150 - Data on File – Sensar not associated with glistenings – Literature analysis. 2013. REF2014OTH0002.
    6. Nagata M, et al. Clinical evaluation of the transparency of hydrophobic acrylic intraocular lens optics. J Cataract Refract Surg. 2010;36(12):2056-2060. REF2015CT0080.
    7. Christiansen G, et al. Glistenings in the AcrySof® intraocular lens: Pilot study. J Cataract Refract Surg. 2001;27(5):728-733. REF2014MLT0005.
    8. Colin J, et al. Incidence of glistenings with the latest generation of yellow-tinted hydrophobic acrylic intraocular lenses. J Cataract Refract Surg. 2012;38(7):1140-1146. REF2014MLT0006.
    9. Gunenc U, et al. Effects on visual function of glistenings and folding marks in AcrySof® intraocular lenses. J Cataract Refract Surg. 2001;27(10):1611-1614. REF2014MLT0011.
    10. Van der Mooren M, Franssen L, Piers P. Effects of glistenings in intraocular lenses. Biomed Opt Express. 2013;4(8):1294-1304. REF2014OTH0139. 
    11. Calculated based on Holladay I formula: Holladay JT, Prager TC, Chandler TY, Musgrove KH, Lewis JW, Ruis RS. A three-part system for refining intraocular lens power calculations. J Cataract Refract Surg. 1988;14(1):17-24. REF2014CT0092.
     
     
    © Johnson & Johnson Surgical Vision, Inc. 2022.
     
    For healthcare professionals only. Please reference the Instructions for Use for a complete list of Indications and Important Safety Information and contact our specialists in case of any question.

    PP2022MLT4205